Search Results

Filter
  • 1-10 of  4,033 results for ""BNT162 Vaccine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2.

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Sep; Vol. 146, pp. 107111. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511

Record details

×
Academic Journal

Hybrid immunity after BNT162b2 Covid-19 vaccine administration in children aged 5 to 11 years.

  • Authors : Tsampalieros A; Children's Hospital of Eastern Ontario Research Institute, Ottawa, Canada.; Zemek R

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Vaccine [Vaccine] 2024 Aug 13; Vol. 42 (20), pp. 125981. Date of Electronic Publication: 2024 May 23.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Follow-up of immune response in patients with common variable immunodeficiency following SARS-CoV-2 vaccination.

  • Authors : Gutiérrez-Bautista JF; Departamento de Bioquímica, Biología Molecular e Inmunología III, University of Granada, Granada, Spain.; Servicio de Análisis Clínicos e Inmunología, University Hospital Virgen de las Nieves, Granada, Spain.

Subjects: Common Variable Immunodeficiency*/Common Variable Immunodeficiency*/Common Variable Immunodeficiency*/immunology ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control Bruton type agammaglobulinemia

  • Source: Clinical and experimental immunology [Clin Exp Immunol] 2024 Aug 09; Vol. 217 (3), pp. 253-262.Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy.

  • Authors : Sieghart D; Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria.; Hana CA

Subjects: Immunization, Secondary* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology SARS-CoV-2 variants

  • Source: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2024 Aug; Vol. 173, pp. 105661. Date of Electronic Publication:Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9815671 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV.

  • Authors : Liu WD; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan. Electronic address: .

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood

  • Source: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2024 Aug; Vol. 57 (4), pp. 554-563. Date of Electronic Publication: Publisher: published by Elsevier for the Taiwan Society of Microbiology Country of Publication: England NLM ID: 100956211 Publication Model: Print-Electronic

Record details

×
Academic Journal

Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; Health Personnel* SARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2024 Jul 25; Vol. 42 (19), pp. 4011-4021. Date of Electronic Publication: 2024 May 17.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection.

  • Authors : Lee KY; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Song KH

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control COVID-19 breakthrough infectionsSARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2024 Jul 25; Vol. 42 (19), pp. 3953-3960. Date of Electronic Publication: 2024 May 09.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.

  • Authors : Jongkees MJ; Department of Internal Medicine, Section Infectious Diseases, and Department of Medical Microbiology and Infectious Diseases.; Tan NH

Subjects: Immunization, Secondary* ; HIV Infections*/HIV Infections*/HIV Infections*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: AIDS (London, England) [AIDS] 2024 Jul 15; Vol. 38 (9), pp. 1355-1365. Date of Electronic Publication: 2024 May 28.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage

  • Source: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3819-3829. Date of Electronic Publication: 2024 May 06.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The association between BNT162b2 vaccinations and incidence of immune-mediated comorbidities.

  • Authors : Shani M; Department of Family Medicine Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Family Medicine Central District, Clalit Health Service, Rehovot, Israel. Electronic address: .

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3830-3837. Date of Electronic Publication: 2024 May 10.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  4,033 results for ""BNT162 Vaccine""